Filter News
Area of Research
- (-) Isotopes (5)
- (-) Materials for Computing (2)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (17)
- Clean Energy (26)
- Computational Biology (1)
- Computer Science (1)
- Fusion and Fission (4)
- Materials (15)
- National Security (12)
- Neutron Science (35)
- Nuclear Science and Technology (7)
- Supercomputing (31)
News Topics
- (-) Biomedical (3)
- (-) Coronavirus (1)
- (-) Neutron Science (2)
- (-) Space Exploration (2)
- Bioenergy (1)
- Biology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Computer Science (4)
- Decarbonization (1)
- Energy Storage (2)
- Isotopes (15)
- Materials (4)
- Materials Science (5)
- Microscopy (1)
- Nanotechnology (3)
- National Security (1)
- Nuclear Energy (2)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (1)
- Simulation (1)
- Sustainable Energy (1)
- Transportation (2)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
In June, ORNL hit a milestone not seen in more than three decades: producing a production-quality amount of plutonium-238
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.
On Feb. 18, the world will be watching as NASA’s Perseverance rover makes its final descent into Jezero Crater on the surface of Mars. Mars 2020 is the first NASA mission that uses plutonium-238 produced at the Department of Energy’s Oak Ridge National Laboratory.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.